معرفی
Stephanie Schwartz is a researcher in the Department of Immunobiology at Yale School of Medicine, affiliated with the Braun Lab. Her work focuses on translational immunology and cancer immunotherapy, particularly targeting immune checkpoints and tumor microenvironment components.
Research Interests: Dr. Schwartz's research spans immunology and oncology, with emphasis on immuno-oncology, tumor microenvironment dynamics, myeloid cell function, fibroblast plasticity, and immune checkpoint modulation. Her studies contribute to the development of novel immunotherapeutic agents targeting pathways such as TIM-3, SHP2, and TGFβ.
Publication Trends: Her recent work, published in journals like Nature Communications and Science Reports, demonstrates a strong focus on mechanistic insights into how immunotherapies modulate both tumor-intrinsic and immune-extrinsic pathways to enhance anti-tumor immunity. There is a clear trajectory toward understanding stromal-immune crosstalk and developing lineage-specific T cell engaging antibodies.
Awards and Recognition:
- No scientific awards listed in the provided text.
Advising and Grants: There is no information available regarding students advised or grants received. However, her active involvement in multi-investigator research suggests collaboration within funded projects at Yale.
Labs and Teams: Stephanie Schwartz is part of the Braun Lab at Yale School of Medicine, a research group dedicated to advancing fundamental and translational understanding of the immune system in cancer. The lab integrates immunological, genomic, and computational approaches to develop novel cancer therapies.
